Publication | Open Access

DEXI, a candidate gene for type 1 diabetes, modulates rat and human pancreatic beta cell inflammation via regulation of the type I IFN/STAT signalling pathway

InflammationType 1Insulin SignalingAutoimmune DiseaseInsulin ManagementDiabetesImmunologyChronic InflammationAutoimmunityDiabetes MellitusMedicineCell BiologyCell SignalingCandidate Gene